key: cord-0709141-14xw60n9 authors: Johnson, Stacy A.; Horton, Devin J.; Fuller, Matthew J.; Yee, Jane; Aliyev, Nijat; Boltax, Jonathan P.; Chambers, Jefferson H.; Lanspa, Michael J. title: Patient-directed Prone Positioning in Awake Patients with COVID-19 Requiring Hospitalization (PAPR) date: 2021-03-30 journal: Annals of the American Thoracic Society DOI: 10.1513/annalsats.202011-1466rl sha: b08084c4a69e99d5788cd8125c6ef5ee07ad2864 doc_id: 709141 cord_uid: 14xw60n9 nan evaluating medical content is unclear, and the increasing number of research manuscripts in the top search results are less relevant and more difficult for patients to interpret. Healthcare organizations that create websites for patient education purposes also risk losing their viewership if they unknowingly miss a specific algorithm criterion, emphasizing the importance of familiarization with these algorithms and continual analysis of their website's search metrics. In summary, we show that the currently available Internet resources on IPF are of higher content and quality compared with 2015, but there are now less patient-relevant resources appearing in the top search results. Healthcare organizations not only must produce highquality online content for patients but also should remain informed on changing search engine algorithms so their resources reach the patients they intend to educate. To the Editor: Before coronavirus disease (COVID-19), reports of prone positioning in nonintubated patients with acute respiratory distress syndrome suggested it may improve oxygenation and avert intubation (1) (2) (3) (4) . This potential value was magnified by the COVID-19 pandemic, prompting clinicians to implement prone positioning protocols to manage the surge of patients presenting with acute hypoxic respiratory failure (5-7). We aimedto assess the feasibility and efficacy of a patient-directed prone positioning protocol compared with usual care in nonintubated, spontaneously breathing patients hospitalized with COVID-19. Patients. We conducted a nonblinded pragmatic randomized controlled trial in symptomatic patients hospitalized with suspected or laboratory-confirmed COVID-19. Patients were enrolled within 48 hours of admission from April 29 to August 6, 2020. Eligibility for enrollment required symptoms of COVID-19 combined with either a high clinical suspicion and a pending COVID-19 assay or a positive COVID-19 assay within 10 days. We excluded patients if they were unable to change position without assistance, pregnant, incarcerated, admitted to an intensive care unit (ICU) or transfer was imminent, mechanically ventilated, or receiving hospice. Intervention. Patients were randomized using a 1:1 allocation to prone positioning or usual care. Those randomized to prone positioning received verbal and written instructions explaining the protocol and a tracking log, and they were offered a massage therapy cushion for comfort. Nursing documentation of patient position was collected as a secondary measure of protocol adherence. During the day, patients were instructed to position themselves in a prone (preferred), left-lateral, or right-lateral (alternati++) position every 4 hours for a duration of 1-2 hours or as long as tolerated. At night, patients were allowed to sleep in any position. Nursing staff did not instruct patients to change positions. Endpoints. The primary endpoint was the change in partial pressure of oxygen (Pa O 2 ) to fraction of inspired oxygen (FI O 2 ) ratio at 72 hours after admission. Secondary endpoints were change in Pa O 2 /FI O 2 at 48 hours, need for endotracheal intubation, ICU transfer, escalation in oxygen delivery system, length of stay, ventilator-free days, and in-hospital mortality. We performed nonlinear imputation of Pa O 2 /FI O 2 from oxygen saturation (Sp O 2 )/FI O 2 at the time of admission and 48 and 72 hours after admission (8) . We assessed 238 patients for eligibility; 76 did not meet inclusion criteria, 51 patients declined to participate, 42 patients were already admitted to an ICU or transfer was imminent, and 39 patients were unable to provide consent. Our target enrollment was 60 patients; however, after a prespecified interim safety analysis, enrollment was stopped because of a lack of protocol adherence. A total of 30 patients were randomized, with 15 (50%) to prone positioning and 15 (50%) to usual care. Baseline characteristics were balanced between groups (Table 1) . Interim analysis revealed that protocol adherence was poor ( Table 2) . None of the patients completed the tracking log despite in-person or telephone reminders. Nursing documentation was available for every patient and was used in place of the tracking log. Only six (40%) patients in the pronepositioningarm wereobservedintheproneposition at least once within 72 hours ofadmission ( Table 2 ). The cumulative time spent prone accounted for only 2.4% of the total time within the first 72 hours of admission (censored for discharge within 72 h), with a mean (95% confidence interval [CI]) duration of 1.6 (0.2-3.1) hours. Eleven (36.7%) patients required supplemental oxygen upon admission, and the median (interquartile range) Sp O 2 was 94% ; P = 0.036). Twelve (80%) patients in the prone positioning arm required an escalation in oxygen delivery system, five (33.3%) patients were transferred to the ICU, and two (13.3%) required endotracheal intubation/mechanical ventilation. Two deaths occurred, both in the prone positioning arm, and were deemed unrelated to study procedures. No study-related adverse events were observed. In this pragmatic randomized controlled trial, we investigated the feasibility and efficacy of patient-directed prone positioning among nonintubated, spontaneously breathing patients hospitalized with COVID-19. We found that adherence to our prone positioning protocol was very low, suggesting that a patient-directed approach is not feasible. Our protocol appeared safe, although it did not improve oxygenation, an unexpected finding. Despite receiving verbal and written instructions and either telephone or in-person follow-up, none of the participants tolerated or adhered to the protocol as designed. Most patients verbalized laying prone one or two times daily for 30-90 minutes within the first 72 hours of hospitalization. Nursing documentation confirmed poor protocol adherence, with only 40% of patients assigned to the intervention being observed in the prone position. This observation reinforced our decision to stop enrollment early and conclude our protocol is not feasible. It is possible a nursing-directed protocol may improve adherence, though we opted against this approach to minimize contagion risk. Given the considerable physiologic evidence for improved oxygenation in the prone position combined with the aforementioned poor protocol adherence, it is difficult to draw inferences from our primary and secondary outcomes. The lack of improvement in Pa O 2 /FI O 2 observed at 72 and 48 hours may represent the natural disease course of COVID-19, with little to no measurable effect of prone positioning. Our study has several limitations, including the small sample size, which limits the power to detect outcome differences; missing data from tracking logs; lack of protocol adherence; and use of a surrogate outcome measure (i.e., imputed Pa O 2 /FI O 2 ). Many patients (63.3%) did not require supplemental oxygen upon admission, suggesting that they were less acutely ill compared with other studied cohorts, possibly accounting for their lack of adherence and improvement (2, 6, 9) . Regardless, we believe our results are informative to future studies and urge investigators to develop respiratory therapy-(9) or nursing-directed protocols rather than relying on patient-directed protocols. Conclusions. Our results suggest that patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19. No improvements in oxygenation were observed at 72 or 48 hours. ; P = 0.036). Twelve (80%) patients in the prone positioning arm required an escalation in oxygen delivery system, five (33.3%) patients were transferred to the ICU, and two (13.3%) required endotracheal intubation/mechanical ventilation. Two deaths occurred, both in the prone positioning arm, and were deemed unrelated to study procedures. No study-related adverse events were observed. In this pragmatic randomized controlled trial, we investigated the feasibility and efficacy of patient-directed prone positioning among nonintubated, spontaneously breathing patients hospitalized with COVID-19. We found that adherence to our prone positioning protocol was very low, suggesting that a patient-directed approach is not feasible. Our protocol appeared safe, although it did not improve oxygenation, an unexpected finding. Despite receiving verbal and written instructions and either telephone or in-person follow-up, none of the participants tolerated or adhered to the protocol as designed. Most patients verbalized laying prone one or two times daily for 30-90 minutes within the first 72 hours of hospitalization. Nursing documentation confirmed poor protocol adherence, with only 40% of patients assigned to the intervention being observed in the prone position. This observation reinforced our decision to stop enrollment early and conclude our protocol is not feasible. It is possible a nursing-directed protocol may improve adherence, though we opted against this approach to minimize contagion risk. Given the considerable physiologic evidence for improved oxygenation in the prone position combined with the aforementioned poor protocol adherence, it is difficult to draw inferences from our primary and secondary outcomes. The lack of improvement in Pa O 2 /FI O 2 observed at 72 and 48 hours may represent the natural disease course of COVID-19, with little to no measurable effect of prone positioning. Our study has several limitations, including the small sample size, which limits the power to detect outcome differences; missing data from tracking logs; lack of protocol adherence; and use of a surrogate outcome measure (i.e., imputed Pa O 2 /FI O 2 ). Many patients (63.3%) did not require supplemental oxygen upon admission, suggesting that they were less acutely ill compared with other studied cohorts, possibly accounting for their lack of adherence and improvement (2, 6, 9) . Regardless, we believe our results are informative to future studies and urge investigators to develop respiratory therapy-(9) or nursing-directed protocols rather than relying on patient-directed protocols. Conclusions. Our results suggest that patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19. No improvements in oxygenation were observed at 72 or 48 hours. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS Response to the prone position in spontaneously breathing patients with hypoxemic respiratory failure Awake prone positioning for non-intubated oxygen dependent COVID-19 pneumonia patients Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients Guidance and patient instructions for proning and repositioning of awake, nonintubated COVID-19 patients NIH/NHLBI PETAL Network Collaborators. Nonlinear imputation of PaO 2 / FiO 2 from SpO 2 /FiO 2 among patients with acute respiratory distress syndrome Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre highdependency unit experience Coronavirus disease (COVID-19) caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from China in December 2019, leading to a global pandemic (1) . Approximately 17% of patients admitted to hospital require critical care, the majority of whom undergo mechanical ventilation (MV) for pneumonia complicated by hypoxemia (2) .High-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) are recognized treatments for hypoxemic respiratory failure caused by community-acquired pneumonia (CAP) (5-7). HFNC and CPAP may represent definitive therapy, avoiding unnecessary MV, or provide bridging respiratory support that offsets the need for immediate MV, preserving finite critical care resources. The ratio of oxygen saturation (ROX) index is used to predict the failure of HFNC in the treatment of CAP (6, 7) . There are little published data describing the use of the ROX index to guide use of HFNC to treat COVID-19-associated respiratory failure; we provide further evidence to validate ROX index use in this setting (8, 9) . The ROX index was developed as a simple bedside test to predict the failure of HFNC and need for MV, although patients with viral pneumonia were likely underrepresented in derivation and validation studies (6) .We undertook a retrospective observational study of individuals with laboratory-confirmed COVID-19 presenting to a single East LondonhospitalbetweenMarch16,2020,andApril6,2020.Patientswho received HFNC, CPAP, or MV were identified. Electronic notes review captured demographic data and clinical and respiratory parameters.Of 393 inpatients with laboratory-confirmed COVID-19 during the study period, 255 individuals (255/393; 65.0%) were eligible for HFNC or CPAP as determined by the treating clinicians, consistent with national and local guidelines (10). A total of 108 individuals (108/255, 42.4%) received HFNCorCPAP;69individualsreceivedHFNConly(63.8%),18 received CPAP only (16.7%), and 21 received both devices (19.4%; Table 1 ). The majority of individuals receiving HFNC and/or CPAP experienced severe outcomes, defined as mortality or MV at 30-day follow-up (77/108; 71.3%). Most individuals who were deemed eligible for CPAP and HFNC at the time of admission were judged by treating clinicians not to require devices (147/255; 57.6%), and the majority of these individuals experienced nonsevere outcomes (138/147; 93.8%).